Explore
Trendline
Ono Pharma to Present New Cancer Treatment Data at ASCO 2026 Meeting in Chicago
Ono Pharma to Present New Cancer Treatment Data at ASCO 2026 Meeting in Chicago
Read More
Trendline
Pfizer Showcases Oncology Innovations at ASCO 2026, Highlighting New Standards of Care
Pfizer Showcases Oncology Innovations at ASCO 2026, Highlighting New Standards of Care
Read More
Trendline
Immunome to Present Phase 3 RINGSIDE Trial Data at ASCO Annual Meeting
Immunome to Present Phase 3 RINGSIDE Trial Data at ASCO Annual Meeting
Read More
Trendline
IDEAYA Biosciences to Present Phase 2/3 Trial Data on Darovasertib at ASCO 2026
IDEAYA Biosciences to Present Phase 2/3 Trial Data on Darovasertib at ASCO 2026
Read More
Trendline
Forlong Biotechnology to Present Clinical Data on FL115 for Advanced Solid Tumors at ASCO 2026
Forlong Biotechnology to Present Clinical Data on FL115 for Advanced Solid Tumors at ASCO 2026
Read More
Trendline
Obsidian Therapeutics to Present Phase 2 Data on OBX-115 for Advanced Melanoma at ASCO 2026
Obsidian Therapeutics to Present Phase 2 Data on OBX-115 for Advanced Melanoma at ASCO 2026
Read More
Trendline
Dizal to Present Key Developments in NSCLC Treatments at ASCO 2026
Dizal to Present Key Developments in NSCLC Treatments at ASCO 2026
Read More
Trendline
Convergent Therapeutics to Present Phase 2 Data for CONV01-α in Prostate Cancer at ASCO 2026
Convergent Therapeutics to Present Phase 2 Data for CONV01-α in Prostate Cancer at ASCO 2026
Read More
Trendline
Forlong Biotechnology to Present Clinical Data on FL115 at ASCO 2026
Forlong Biotechnology to Present Clinical Data on FL115 at ASCO 2026
Read More
Trendline
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Regulatory Submissions
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Regulatory Submissions
Read More
Trendline
Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence
Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence
Read More
Trendline
Innate Pharma to Present Promising Phase 2 Results for Lung Cancer Treatment at AACR 2026
Innate Pharma to Present Promising Phase 2 Results for Lung Cancer Treatment at AACR 2026
Read More
